Overview

Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections

Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Prospective randomized study comparing different colistin dosing regimens in paediatric cancer patient with MDR gram-negative infection or sepsis
Phase:
Phase 4
Details
Lead Sponsor:
National Cancer Institute, Egypt
Treatments:
Colistin
Polymyxins